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An enhancement of glutamate release from hippocampal neurons has been implicated in long-term
potentiation, which is thought to be a cellular correlate of learning and memory. This phenomenom
appears to be involved the activation of protein kinase C and lipid second messengers have been
implicated in this process. The purpose of this study was to examine how lipid-derived second
messengers, which are known to potentiate glutamate release, influence the accumulation of intra-
terminal free Ca2+, since exocytosis requires Ca2+ and a potentiation of Ca2+ accumulation may
provide a molecular mechanism for enhancing glutamate release. The activation of protein kinase
C with phorbol esters potentiates the depolarization-evoked release of glutamate from mossy fiber
and other hippocampal nerve terminals. Here we show that the activation of protein kinase C also
enhances evoked presynaptic Ca2+ accumulation and this effect is attenuated by the protein kinase
C inhibitor staurosporine. In addition, the protein kinase C-dependent increase in evoked Ca2+
accumulation was reduced by inhibitors of phospholipase A2 and voltage-sensitive Ca2+ channels,
as well as by a lipoxygenase product of arachidonic acid metabolism. That some of the effects of
protein kinase C activation were mediated through phospholipase A2 was also indicated by the
ability of staurosporine to reduce the Ca2+ accumulation induced by arachidonic acid or the phos-
pholipase A2 activator melittin. Similarly, the synergistic facilitation of evoked Ca2+ accumulation
induced by a combination of arachidonic acid and diacylglycerol analogs was attenuated by stau-
rosporine. We suggest, therefore, that the protein kinase C-dependent potentiation of evoked glu-
tamate release is reflected by increases in presynaptic Ca2+ and that the lipid second messengers
play a central role in this enhancement of chemical transmission processes.
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INTRODUCTION
The depolarization-dependent increase in the con-
centration of intraterminal free Ca2+ ([Ca2+]i) stimulates
the release of neurotransmitters and it is likely that any
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potentiation of the evoked increase in [Ca2+]i can facil-
itate neurotransmission by enhancing transmitter exo-
cytosis. This enhanced efflux of transmitter, in particular
glutamate, has been implicated in the potentiation of
synapses thought to be involved in learning and memory
(1). The activation of protein kinase C (PKC) has also
been linked to synaptic potentiation (2) and the associ-
ated increase in evoked glutamate release (3,4,5). There-
fore, it is possible that this potentiation of glutamate
exocytosis depends on PKC activation and results in an
increase in [Ca2+]i.
There are several factors known to activate PKC.
First, phorbol esters translocate PKC to cellular mem-
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branes, in a relatively permanent manner, where it phos-
phorylates substrates (6). This translocation/activation of
PKC appears to play a neuromodulatory role, since 4-(3-
phorbol 12,13-dibutyrate (PDBu) enhances depolariza-
tion-evoked glutamate release and presynaptic Ca2+
accumulation (4). In addition, lipid second messengers ac-
tivate PKC. Diacylglycerol (DAG), formed as a result of
the breakdown of phosphatidylinositol 4,5-bisphosphate,
activates PKC by lowering its affinity for Ca2+ (7). Simi-
larly, arachidonic acid (AA), liberated from the sn-2 po-
sition of phospholipids by phospholipase A2 (PLA2),
stimulates PKC (8). Also, a role for lipids in PKC-depen-
dent synaptic potentiation is indicated by the observations
that exogenous AA, or the PLA2-dependent accumulation
of AA, enhances glutamate efflux from nerve terminals (9),
as well as an increase in [Ca2+]i (10). More recently, it was
shown that a combination of low concentrations of AA and
DAG activates PKC (11) and potentiates the evoked efflux
of glutamate from nerve terminals (5) in a synergistic man-
ner. The purpose of the work presented here was to ex-
amine the relationships between the lipid messengers, PKC
activation, presynaptic Ca2+ accumulation and the facilita-
tion of glutamate exocytosis.
Hippocampal mossy fiber synaptosomes (HMFS)
were used as the model for the following studies, since
this preparation contains the presynaptic elements of the
mossy fiber-CA3 synapse and this synapse expresses a
potentiation that is dependent on the facilitation of glu-
tamate exocytosis (12). HMFS respond to depolarizing
stimuli with increases in [Ca2+]i and glutamate efflux
(13,14). In addition, the synaptosomes contain PKC is-
oforms, some of which are activated by phorbol esters
(4) and they accumulate unesterified AA upon depolar-
ization (14). Here it is shown that the activation of PKC
leads to a potentiation of Ca2+ accumulation, whether
induced by membrane depolarization or an ionophore.
In addition, inhibition of PKC attenuated the increase in
evoked Ca2+ accumulation induced by phorbol esters,
unesterified AA or the PLA2 activator melittin. A phys-
iological role for AA in presynaptic processes was in-
dicated by the observation that low concentrations of the
fatty acid were able to enhance depolarization-evoked
Ca2+ accumulation when DAG analogs were present.
Again, this effect was attenuated by PKC inhibition. It
was also observed that certain receptor agonists mim-
icked the effects of exogenous DAG analogs on Ca2+
availability and glutamate exocytosis. Based on these
observations, we suggest that the short-term effects of
PKC activation on glutamate exocytosis may be linked
to an enhancement in presynaptic Ca2+ concentrations
and that the lipid-derived second messengers are in-
volved in this facilitation.
EXPERIMENTAL PROCEDURE
Preparation of Hippocampal Mossy Fiber Synaptosomes. Six to
eight adult Sprague-Dawley rats (150 - 200 g) were used to obtain
mossy fiber synaptosomes. Details of this procedure have been de-
scribed (13). The final pellet was resuspended in oxygenated Krebs-
bicarbonate buffer (122 mM NaCl, 3.1 mM KC1, 1.2 mM MgSO4, 0.4
mM KH2PO4, 5 mM NaHCO3, 20 mM sodium N-tris[hydroxymethyl]-
methyl-2-aminoethane-sulfonic acid (Na-TES), 11 mM D-glucose; pH
7.4). Aliquots were taken to determine protein concentration using the
Warburg-Christian assay (15).
Measurement of Intracellular Ca2+. Synaptosomes were split into
5 mg aliquots in Ca2+-free Krebs-bicarbonate buffer containing 0.5%
fatty acid free bovine serum albumin and incubated in a shaking water
bath at 30°C for 5 minutes to remove unesterified fatty acids and fa-
cilitate the movement of fura-2AM, a fluorescent Ca2+ dye, into the
synaptosomes (16). Synaptosomes were pelleted in a microfuge, the
supernatant was removed and the synaptosomes were washed once
with Krebs-bicarbonate buffer. Fura-2AM (5 |XM) was loaded into the
synaptosomes for 20 min at 30°C. During this incubation period cy-
tosolic esterases hydrolyze the acetoxymethyl esters of fura-2AM trap-
ping the dye inside the synaptosomes. Synaptosomes were centrifuged
as previously mentioned and washed twice in Krebs-bicarbonate buffer
to remove any external dye. Synaptosomes were resuspended in ox-
ygenated (95% O2, 5% CO2) Krebs-Ringer buffer (128 mM NaCl, 5
KCl, 1.2 mM MgSO4, 1 mM CaCl2, 1 mM Na2HPO4, 10 mM D-
glucose and 20 mM MOPS; pH 7.4) and incubated at 30°C for 15 min
to allow for Ca2+ equilibration within the nerve terminals.
Following incubation, aliquots of synaptosomes (0.25 mg protein)
were added to a quartz cuvette containing Krebs-Ringer buffer and
placed in a Perkin Elmer LS-5B spectrofluorimeter. Synaptosomes
were maintained in suspension throughout the experiment with a mag-
netic stir bar. Experimental treatments were added directly to the cu-
vette 2 min prior to depolarization. All treatments were checked for
autofluorescence and treatments diluted with DMSO were added such
that the total concentration of DMSO in the cuvette did not exceed
0.1%. This concentration of DMSO did not affect Ca2+ measurements.
The concentration of intracellular Ca2+ was determined using a
ratio method (17), which has been routinely employed in this labora-
tory (18,10). Rmax was determined by lysing the cells with 0.1% so-
dium dodecylsulfate (SDS) and Rmin was determined by binding the
available Ca2+ with 8 mM EGTA. Results are shown as nM changes
in the concentrations of intraterminal free Ca2+ from resting levels.
Glutamate Release. Isolated nerve terminals were superfused in
6 parallel chambers maintained at 30°C at a rate of 0.5 mL/min. Four-
minute fractions were collected and assayed for glutamate using a
microfluorometric assay (19) as described (9,13). Spontaneous gluta-
mate efflux was determined by superfusion with control buffer.
Evoked release was calculated as the difference between spontaneous
efflux and the total amount of glutamate released in the presence of
stimuli. Evoked release is expressed as picomoles of glutamate re-
leased per minute per mg of protein.
The lipid second messengers and most other special chemicals
used in this study were obtained from the Sigma Chemical Company.
Fura-2AM was purchased from Molecular Probes, while norepineph-
rine bitartrate was obtained from Research Biochemicals Inc.
Statistical Analyses. Data are expressed as the means obtained
from multiple experiments ± SEM. Statistical significance among
treatment groups was determined using ANOVA and the Newman-
Keuls pairwise comparison test. A value is considered significant at p
< 0.05.
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Fig. 1. Effects of 4|i-phorbol 12,13-dibutyrate (PDBu) on K+-evoked
Ca2+ accumulation in the absence or presence of staurosporine (STAU;
1 u,M). HMFS were prepared and [Ca2+]i was measured as described.
Synaptosomes were exposed to each treatment for 2 min prior to de-
polarization with 25 mM KCl. CNTL = depolarization (25 mM K+)
without treatment. 4a = 4a-phorbol (10 u,M). Results are expressed
as the nM evoked changes in [Ca2+]i ± SEM. Different letters repre-
sent significantly different values; p < 0.05.
RESULTS
Role of PKC in Depolarization-Evoked Ca2+ Ac-
cumulation. The resting level of intraterminal free Ca2+
in mossy fiber nerve terminals was 338 ± 5.2 nM. De-
polarization with 25 mM KCl stimulated a 126 nM in-
crease in [Ca2+]i which was inhibited 21% by the protein
kinase inhibitor, staurosporine (Fig. 1). PDBu poten-
tiated the evoked accumulation of Ca2+ in a dose-depen-
dent manner and this enhancement was blocked by
Fig. 2. 8-Bromo-A23187 (A23187)-stimulated increases in [Ca2+]i in
the absence or presence of PDBu. Nerve terminals were prepared and
[Ca2+]i was quantified as described. Synaptosomes were exposed to
A23187 at the concentrations shown in the absence (closed circles) or
presence (closed squares) of PDBu (10 |lM) preincubation for 2 min.
Results are shown as nM stimulated changes in [Ca2+]i ± SEM. * =
significantly different from concentration-matched A23187 controls; p
< 0.05.
staurosporine (1 jiM). The inactive 4a-phorbol had no
effect on evoked Ca2+ accumulation.
The PDBu-enhanced Ca2+ accumulation was atten-
uated by the PLA2 inhibitors, 4-bromophenacyl bromide
(4-BPB; 50 nM) and nordihydroguaiaretic acid (NDGA;
100 |xM), by 44 or 53%, respectively (Table I). The
lipoxygenase product of AA metabolism, 12-S-hydrox-
yeicosatetraenoic acid (12-HETE; 10 ^M), inhibited the
K+-evoked PDBu-enhanced Ca2+ accumulation by 55%.
In addition, the voltage-sensitive Ca2+ channel (VSCC)
blockers verapamil (300 uM) or cinnarizine (20 jiM)
inhibited Ca2+ accumulation by 77 or 81%, respectively.
Effects of PDBu on Ca2+ lonophore-Induced Ca2+
Accumulation. The Ca2+ ionophore, 8-Bromo-A23187
(A23187), stimulated a dose-dependent increase in the
accumulation of intraterminal free Ca2+, since 0.01,0.05,
0.1, 0.5 or 1 uM A23187 increased [Ca2+]i by 28, 40,
53, 132 or 242 nM, respectively. PDBu (10 uM) poten-
tiated these ionophore-induced increases in [Ca2+]i by 43,
72, 81, 37 or 21%, respectively (Fig. 2).
Effects of PDBu and Staurosporine on Ca2+ Accu-
mulation Induced by Melittin or AA. The PLA2 activator
melittin stimulated a dose-dependent increase in [Ca2+]i,
since 0.01, 0.05 or 0.1 |0,M melittin increased [Ca2+]i by
22, 48 or 88 nM (Fig. 3). This effect was not altered by
10 (O.M PDBu. However, 0.2 |jM staurosporine inhibited
the Ca2+ accumulation induced by 0.05 or 0.1 jiM mel-
ittin by 52 or 22%, respectively. Likewise, AA stimu-
lated a dose-dependent enhancement of Ca2+
accumulation which was unaffected by 10 (4.M PDBu
Table I. Effects of PLA2 Inhibitors, 12-HETE and Ca2+ Channel
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HMFS were prepared and [Ca2+]i was determined as described. Treat-
ments were applied to the nerve terminals 2 min before depolarization
with 25 mM KCl. Results are expressed as the evoked nM change in
[Ca2+]i from resting levels ± SEM in the first column and as the %
of inhibition from PDBu-enhanced evoked Ca2+ accumulation in the
second column. PDBu = 4B-phorbol 12,13-dibutyrate, 4-BPB = 4-
bromophenacyl bromide, NDGA = nordihydroguaiaretic acid, 12-
HETE = 12-S-hydroxyeicosatetraenoic acid, * = significantly
different from the PDBu-enhanced evoked change in [Ca2+]i; p < 0.05.
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Fig. 3. Effects of PDBu on melittin-induced Ca2+ accumulation in the
absence or presence of staurosporine. Synaptosomes were isolated as
described and Ca2+ accumulation is expressed as the nM change ±
SEM. Nerve terminals were exposed to melittin at the concentrations
given (closed circles). Melittin-treated synaptosomes were exposed to
10 (iM PDBu (closed squares) or 0.2 |xM staurosporine (closed tri-
angles) for 2 min prior to stimulation with melittin. * = significantly
different from the melittin alone value; p < 0.05.
Fig. 4. Effects of PDBu on arachidonic acid (AA)-induced Ca2+ ac-
cumulation in the absence or presence of staurosporine. HMFS were
prepared and [Ca2+]i was determined as described. HMFS were stim-
ulated with AA at the concentrations shown (closed circles). AA
treated synaptosomes were exposed to 10 \iM PDBu (closed squares)
or 0.2 u,M staurosporine (closed triangles) for 2 min prior to exposure
to AA. Results are expressed as the stimulated change in [Ca2+]i ±
SEM. * = significantly different from the AA alone value; p < 0.05.
(Fig. 4). However, 0.2 |oM staurosporine attenuated this
accumulation by 44, 37 or 34% when the nerve terminals
were stimulated with 15, 25 or 35 uM AA, respectively.
Synergistic Facilitation of Depolarization-Induced
Ca2+ Accumulation by AA and OAG. The effects of AA
and the DAG analog oleoyl-acetyl-glycerol (OAG) on
depolarization-evoked intraterminal free Ca2+ accumu-
lation were investigated and the results are shown in Fig.
5. Neither OAG (1 |aM) nor AA (1 |iM) had any effect
Fig. 5. Effects of staurosporine on arachidonic acid/oleyol-acetyl-glyc-
erol-dependent facilitation of K+-evoked Ca2+ accumulation. Nerve ter-
minals were prepared and [Ca2+]i was determined as described. HMS
were exposed to combinations of STAU (1 |xM), oleoyl-acetyl-glycerol
(OAG; 1 U.M), or AA (1 |iM), for 2 min prior to depolarization with
25 mM KCl. CNTL = depolarization without treatment. Results are
expressed as nM changes in [Ca2+]i ± SEM. Different letters represent
significantly different values; p < 0.05.
on K+-evoked Ca2+ accumulation. However, the presence
of a combination of OAG and AA enhanced evoked Ca2+
accumulation by 25% and this effect was attenuated 74%
by 1 |^M staurosporine. Neither OAG nor AA affected
the resting [Ca2+]i at the concentrations used. Similar re-
sults were obtained using a less permeable analog of
DAG, 1,2-dioctanoyl-sn-glycerol (DiC8). Here, the pres-
ence of 0.01, 0.1 or 0.5 |J,M DiC8 had no effect on K+-
evoked Ca2+ accumulation, but the same concentrations
enhanced evoked Ca2+ accumulation by 17, 21, or 30%
in the presence of 1 |^M AA, respectively.
Effects of Receptor Agonists and AA on Depolari-
zation-Evoked Ca2+ Accumulation and Glutamate Re-
lease. Several receptor agonists were used in an effort
to stimulate the production of endogenous DAG, which
may potentiate the evoked accumulation of intraterminal
free Ca2+ in the presence of AA. Norepinephrine (NE)
in the presence of 1 j^M AA enhanced evoked Ca2+ ac-
cumulation by 22% (Fig. 6A). However, NE alone in-
creased [Ca2+]i by 7% over the depolarization evoked
control. NE alone also caused an increase in K+-evoked
glutamate release to 23% above the control. Although
this value was increased to 34% of the control in the
presence of AA, the difference was not statistically sig-
nificant from evoked glutamate release potentiated by
NE alone (Fig. 6B).
Acetylcholine (ACh) in the presence of 1 jaM AA
stimulated an 18% increase in evoked Ca2+ accumulation
over that seen with ACh alone (Fig. 7A). Although, this
increase was not significantly different than the K+-
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Fig. 6. Effects of NE plus AA on K+-evoked Ca2+ accumulation and
glutamate release. Nerve terminals were prepared as described. Panel
A: [Ca2+]i was determined as mentioned previously. The HMFS were
exposed to NE (10 \iM) with or without AA (1 (iM) for 2 min prior
to depolarization with 25 mM KCl. Results are shown as the depolar-
ization-evoked change in [Ca2+]i for each treatment divided by the K+-
evoked stimulus control and expressed as % ± SEM. * = significantly
different from stimulus control (25 mM K+); p < 0.05. Panel B: The
efflux of glutamate was determined as described. Nerve terminals were
exposed to NE (5 |̂ M) with or without AA (50 (iM) for 4 min prior
to a 2 min pulse of 25 mM KCl. Results are shown as % stimulus
control ± SEM.
Fig. 7. Effects of ACh or tACPD, in the presence or absence of AA,
on K+-evoked Ca2+ accumulation. HMFS were prepared as described
and [Ca2+]i was determined as mentioned previously. The nerve ter-
minals were exposed to ACh (10 uM; Panel A) or tACPD (1 nM;
Panel B) with or without AA (1 (J.M) for 2 min prior to depolarization
with 25 mM KCl. Results are shown as % stimulus control ± SEM.
* = significantly different from depolarized, ACh treated value; p <
0.05.
evoked Ca2+ accumulation in stimulus controls, it was
different from the evoked Ca2+ accumulation observed
in the presence of ACh alone.
The metabotropic glutamate receptor agonist t-
ACPD had no influence on evoked Ca2+ accumulation at
concentrations ranging from 0.1 to 1 \iM. The lack of
effect at 1 jiM is shown in the presence or absence of 1
|iM AA (Fig. 7B).
DISCUSSION
The potentiation of the mossy fiber/CA3 synapse
appears to involve an increase in evoked glutamate ef-
flux (12) and synaptic potentiation has been associated
with increased Ca2+ accumulation (20). Ultimately, these
effects may involve PKC, since activation of neuronal
PKC facilitates Ca2+-dependent glutamate release from
cerebrocortical and mossy fiber synaptosomes (3,4). In
turn, DAG and AA have been shown to synergistically
activate PKC (21,22), and potentiate synapses in the
CA1 region of the hippocampus (23). These two second
messengers have also been found to synergistically fa-
cilitate glutamate release from mossy fiber nerve termin-
als (5). The purpose of our investigation was to
determine if factors which activate PKC, and in effect
enhance glutamate release, also lead to an increase in
[Ca2+]i.
We observed that the activation of PKC potentiated
depolarization-evoked Ca2+ accumulation and that PLA2
inhibitors, a lipoxygenase product and Ca2+ channel
blockers attenuated this effect. Also, the ionophore-de-
pendent increase in [Ca2+]i was potentiated by PDBu, but
the Ca2+ accumulation induced by AA or melittin was
not enhanced by the phorbol ester. However, DAG an-
alogs and AA did induce a synergistic facilitation of
evoked Ca2+ accumulation that apparently required PKC
activation. In addition, ACh and NE were able to mimic
the effects of the DAG analogs, while tACPD did not.
Taken together, these results implicate the lipid second
messengers in the PKC-dependent modulations of pre-
synaptic Ca2+ concentrations.
The influence of PDBu on depolarization-evoked
Ca2+ accumulation was consistent with the findings of
other groups (3,4,24). The PKC inhibitor staurosporine
significantly reduces glutamate release from depolarized
nerve terminals exposed to PDBu for 5 min (24). This
attenuation of glutamate release may be due to effects
on Ca2+ concentrations, since we observed that stauros-
porine caused a 43% reduction in evoked Ca2+ accu-
mulation in the presence of PDBu. It should be noted,
however, that staurosporine also attenuated depolariza-
tion-evoked Ca2+ accumulation in the absence of PDBu
and this may be due to the inhibition of previously ac-
tivated mossy fiber PKC (4).
It has been suggested that PKC-dependent phos-
phorylation stimulates PLA2 and leads to AA accumu-
lation, which would further enhance cellular processes.
For example, the activation of glutamate receptors in
brain cortical cultures leads to the Ca2+- and PKC-de-
pendent activation of PLA2 (25). Similarly, PKC-depen-
dent phosphorylation has been implicated in the
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activation of PLA2 in macrophages (26), smooth muscle
(27) and PC 12 cells (28). Here we show that the PLA2
inhibitors, 4-BPB and NDGA, reduced the effects of
PDBu on Ca2+ accumulation, suggesting a role for PKC
in the activation of mossy fiber PLA2, as well as some
involvement of the lipase in the regulation of [Ca2+]i.
These inhibitors also attenuate K+-evoked Ca2+ ac-
cumulation in the absence of PDBu and, based on com-
parisons with past results (14,18), 4-BPB appears to be
equally effective at reducing K+-evoked Ca2+ accumu-
lation in the presence or absence of PDBu. However,
NDGA is less effective at attenuating the PDBu effects,
perhaps because it also inhibits lipoxygenase activity,
which potentiates both evoked glutamate release and
Ca2+ accumulation (14,18). Consistent with this sugges-
tion, we observed that the lipoxygenase product 12-
HETE reduced the PDBu-dependent facilitation of
evoked Ca2+ accumulation by 55%, which is three-fold
greater than the reduction observed in the absence of
PDBu (18). Taken together, these data implicate AA in
the PKC-dependent effects on [Ca2+]i, and again, one of
its lipoxygenase products appeared to attenuate neuro-
transmission processes. These results are consistent with
the recent suggestion that 12-HETE is involved in the
development of long-term depression of hippocampal
synapses (29).
We also report that PDBu enhanced the Ca2+ ac-
cumulation induced by the Ca2+ ionophore A23187. This
effect on [Ca2+]i was consistent with the observation that
PKC activation also potentiates ionophore-induced glu-
tamate release (30). It was suggested that this facilitation
may depend on the ability of Ca2+ ionophores to depo-
larize neuronal membranes (31) and open voltage-gated
Ca2+ channels. This proposal was supported by the
partial attenuation of ionophore-induced glutamate re-
lease from mossy fiber terminals by VSCC blockers
(30).
Although PDBu enhanced the Ca2+ accumulation
induced by depolarization and A23187, it did not in-
crease that due to melittin or AA. Perhaps AA and PDBu
modulated Ca2+ accumulation through similar mecha-
nisms. In fact, AA elicits an increase in [Ca2+]i in mossy
fiber nerve terminals (10) and part of this effect may
depend on the activation of PKC, since cis-unsaturated
fatty acids activate the kinase in the absence of Ca2+ and
phospholipid (8). As with phorbol esters (32), free fatty
acids also are likely to regulate PKC at the membrane
surface, where they increase lipid fluidity (33), which
serves to stabilize PKC (34). Thus, some of the AA ef-
fects are likely to be mediated through the activation of
PKC. Indeed, staurosporine attenuated the effects of
both AA and melittin on [Ca2+]i.
Although, the high concentrations of AA required
to directly stimulate PKC may not be physiologically
relevant (35) and are likely to be involved in ischemia-
induced brain damage (36,37), roles for AA in normal
neuronal functions have been proposed. Recently, it was
shown that low concentrations of AA activate PKC, but
only in the presence of DAG (11,21). Consistent with
the formation of an intrinsically active form of PKC
(38), the combination of AA and DAG induces synaptic
potentiation (23,39) and enhances evoked glutamate re-
lease from HMFS (5). It appeared, from the results pre-
sented here, that this potentiation of neurotransmitter
release was due to an increase in [Ca2+]i, since DAG and
AA synergistically enhanced depolarization-evoked Ca2+
accumulation. That these effects are attenuated by stau-
rosporine and mimicked by PDBu provides strong evi-
dence for PKC involvement in the modulation of both
Ca2+ availability and glutamate release.
Several receptor agonists were used in attempts to
stimulate the production of endogenous DAG. We em-
ployed tACPD, NE and ACh, since the hippocampus is
rich in glutamatergic synapses and receives adrenergic
and cholinergic input from various brain regions (40).
NE enhanced depolarization-evoked Ca2+ accumulation
by itself and the presence of AA caused a further in-
crease in [Ca2+]i. NE also stimulated glutamate release
from resting synaptosomes and its effects on K+-evoked
glutamate efflux showed a facilitory trend. These results
were consistent with the ability of NE to enhance the
magnitude, duration and probability of synaptic poten-
tiation at the mossy fiber synapse (41), which is likely
to occur through the enhancement of Ca2+ influx via volt-
age-gated Ca2+ channels (42).
The other receptor agonists, ACh and tACPD, stim-
ulate the production of DAG (43,44) via the activation
of PLC. ACh is thought to have a neuromodulatory ef-
fect on hippocampal pyramidal cells by stimulating a
slow depolarization via the inhibition of K+ efflux (45).
Presynaptically, ACh has been shown to potentiate glu-
tamate release in the presence of AA (30). Hence,
evoked Ca2+ accumulation displayed a similar pattern,
since ACh enhanced depolarization-evoked Ca2+ accu-
mulation in the presence of AA. Thus, the activation of
ACh receptors may lead to the PLC-dependent produc-
tion of DAG, which potentiates Ca2+ accumulation when
AA is added.
Finally, several groups reported the metabotropic
glutamate receptor agonists and AA show synergistic ef-
fects on neurotransmission. For example, tACPD en-
hances glutamate release from cerebrocortical
synaptosomes and HMFS, but only in the presence of
AA (27,46). Similarly, tACPD and AA enhance synaptic
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transmission in hippocampal slices from the CA1 region
in the absence of tetanic stimulation (47). These effects
may involve the modulation of [Ca2+]i, since depolari-
zation-evoked Ca2+ accumulation is potentiated by 50
|iM tACPD, but only in the presence of 2 |0,M AA (46).
However, we observed no change in the K+-evoked Ca2+
accumulation upon treatment with tACPD and AA. The
discrepancy between these findings and those mentioned
previously could be due to a highly localized increase
in Ca2+ influx into the mossy fiber nerve endings, which
might not be detected using the current techniques. Al-
ternatively, the primary influence of the lipid second
messengers may be mediated through other PKC-depen-
dent processes, such interactions with cytoskeletal com-
ponents, which potentiate evoked glutamate release by
increasing the availability of synaptic vesicles (48).
In summary, activation of PKC stimulated an en-
hancement of evoked Ca2+ accumulation and evidence is
provided that PLA2 may be involved in this PKC-de-
pendent potentiation of evoked Ca2+ accumulation. One
can speculate that pre- and/or postsynaptic PLA2 be-
comes activated in the course of synaptic potentiation
and this leads to an increase in presynaptic AA. This
AA stimulates the activation of PKC, but only when
receptor-derived DAG is present. This activation of PKC
affects both [Ca2+]i and glutamate release. The potentia-
tion of Ca2+ accumulation and glutamate exocytosis may
be functionally related, but further work is needed to
confirm this. Also in question are the receptor subtypes
which are coupled to DAG formation, the mechanisms
for the control and localization of PLA2 and the involve-
ment of Ca2+ in all these processes.
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